Here, we provide an overview of the main activities of TGF-β on macrophages, neutrophils, myeloid-derived suppressor cells (MDSCs), T cells, and cancer-associated fibroblasts that enhance tumor development and progression with some evidence for GI tumors. This evidence concerns the gene TGFB1 and cancer.